Evaluation of standard-of-care intravitreal aflibercept treatment practices in patients with diabetic macular oedema in the UK: DRAKO study outcomes

BACKGROUND/OBJECTIVES: DRAKO (NCT02850263) was a 24-month, prospective, non-interventional, multi-centre cohort study enrolling patients with diabetic macular oedema (DMO) including central involvement. The study evaluated UK standard-of-care intravitreal aflibercept (IVT-AFL) treatment. This analys...

Descripción completa

Detalles Bibliográficos
Autores principales: Sivaprasad, Sobha, Ghanchi, Faruque, Kelly, Simon P., Kotagiri, Ajay, Talks, James, Scanlon, Peter, McGoey, Hellen, Nolan, Andrew, Saddiq, Moneeb, Napier, Jackie, Morgan-Warren, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397211/
https://www.ncbi.nlm.nih.gov/pubmed/36653595
http://dx.doi.org/10.1038/s41433-022-02367-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397211/
https://www.ncbi.nlm.nih.gov/pubmed/36653595
http://dx.doi.org/10.1038/s41433-022-02367-x

Ejemplares similares